Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period.

Losing weight can be a challenge for many. With so many variables present in everyday life, including stress, lack of sleep, ...

A new drug dubbed the “King Kong” of weight-loss jabs will be available in Ireland early next year, it was confirmed yesterday. Mounjaro, a brand name for tirzepatide, can be used to treat ...

Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.

The Mounjaro jab has been branded the “King Kong of weight-loss drugs” and could offer life-changing support for people in the UK struggling with obesity. It’s been advised that people with ...

It comes amid news this week that millions of people will ... Fewer than one in ten patients who meet the criteria for Mounjaro will be given it by the health service over the next three years ...

Weight-loss injection Mounjaro, also known as tirzepatide, could offer hope to those suffering from obesity when it is rolled out on the NHS over a 12-year period. The National Institute for Health ...

Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight ...